Trade ATTO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Attovia Therapeutics, Inc. (ATTO) is trading at US$14.96, up 1.63% today as of Oct 14, 16:00 EDT. The company has a market capitalisation of US$895M. Over the past 52 weeks, ATTO has traded between US$14.23 and US$28.00. On Syfe you can trade ATTO with $0 commission and add it to your watchlist.
| Previous close | US$14.72 |
|---|---|
| Market cap | US$895M |
| 52-week range | US$14.23 – US$28.00 |
| Volume | 359.58K |
| Exchange | US |
Attovia Therapeutics, Inc.
Attovia Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that creates next-generation biologic medicines for immune-mediated diseases. It was founded in 2022 and is headquartered in San Carlos, CA.
Year: 2026
Attovia Therapeutics Q2 Net Loss Widens
Sep 2, 8:48 PM · MT Newswires
Attovia Therapeutics Could Serve as Key Player in Immunology, Inflammation, RBC Says
Aug 31, 3:16 PM · MT Newswires
--Morgan Stanley Initiates Coverage on Attovia Therapeutics With Overweight Rating
Aug 31, 11:05 AM · MT Newswires
--Leerink Partners Initiates Attovia Therapeutics at Outperform With $52 Price Target
Aug 31, 10:49 AM · MT Newswires
--RBC Initiates Attovia Therapeutics at Outperform, Speculative Risk With $45 Price Target
Aug 31, 10:21 AM · MT Newswires
Attovia Therapeutics, Inc. (ATTO) stock is trading at US$14.96, +1.63% from the previous close of US$14.72.
The market cap for Attovia Therapeutics, Inc. (ATTO) stock is approximately US$895M.
The 52-week high for Attovia Therapeutics, Inc. (ATTO) stock is US$28.00.
The 52-week low for Attovia Therapeutics, Inc. (ATTO) stock is US$14.23.
Attovia Therapeutics, Inc. (ATTO) does not currently pay a dividend.
Stay on top of ATTO
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
